Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-01-31

Study Completion Date

2005-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of two asthma treatments by lung function measures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Treatment Of Symptomatic Asthma In Children

NCT00197106

Asthma

COMPLETED PHASE4

Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids

NCT00353873

Asthma

COMPLETED PHASE4

Real-world Effectiveness of Combination Therapy in Asthma

NCT01141465

Asthma

COMPLETED

SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults

NCT00461500

Asthma

COMPLETED PHASE4

Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications

NCT00158834

Asthma

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

Group Type EXPERIMENTAL

Salmeterol/fluticasone propionate

Intervention Type DRUG

Fluticasone propionate

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Salmeterol/fluticasone propionate

Intervention Type DRUG

Fluticasone propionate

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Salmeterol/fluticasone propionate

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently receiving 200-800mcg/day beclomethasone dipropionate.
* sRAW value of 1.3 kPa's.

Exclusion Criteria

* 3 or more courses of oral steroids in last 12 months.

Minimum Eligible Age

4 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

GSK Clinical Trials

Role: STUDY_DIRECTOR

GlaxoSmithKline

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GSK Investigational Site

Wellington, , New Zealand

Site Status

GSK Investigational Site

Manchester, Lancashire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

New Zealand United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

This study has not been published in the scientific literature.

Reference Type BACKGROUND

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.